Eledon Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Irvine, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eledon Pharmaceuticals, Inc. has filed 610 SEC EDGAR filings since 18 Jun 2007

SEC filing history

Showing 251-275 of 607 matching filings.

Per page
25
Current page
11
3

FORM 3 SUBMISSION

Filing date
14 Dec 2020
Reporting date
08 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-251305

S-3

Filing date
11 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K

Filing date
10 Dec 2020
Reporting date
08 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36620

DEFA14A

Filing date
10 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Dec 2020
Reporting date
02 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88334

AMENDMENT NO. 7

Filing date
04 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
20 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88334

AMENDMENT NO. 6

Filing date
20 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K

Filing date
20 Nov 2020
Reporting date
20 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-36620

8-K AMENDMENT NO 1

Filing date
20 Nov 2020
Reporting date
09 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36620

DEF 14A

Filing date
20 Nov 2020
Reporting date
18 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
13 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14A File 001-36620

PRER14A

Filing date
13 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88334

SC 13G filing

Filing date
09 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
09 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Nov 2020
Reporting date
30 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
06 Nov 2020
Reporting date
30 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36620

PRE 14A

Filing date
23 Oct 2020
Reporting date
23 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88334

AMENDMENT NO. 5

Filing date
14 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K

Filing date
06 Oct 2020
Reporting date
05 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
05 Oct 2020
Reporting date
01 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88334

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Filing date
05 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-376405

D filing

Filing date
25 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
24 Sep 2020
Reporting date
14 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .